CHASE DONALD R has filed 1 SEC Form 4 filing across 1 company in the last 90 days — buying. Lifetime open-market purchases: $25K.

Donald R. Chase is listed in SEC filings as a director of Bluejay Diagnostics, Inc. as of May 18, 2026. Public sources referenced in the SEC context do not provide extensive biographical detail beyond his board role, indicating that his prominence in public datasets is primarily due to board membership at Bluejay Diagnostics rather than broader public notoriety.
| Role | Director |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-18 | BJDX | Bluejay Diagnostics, Inc. | P — Open-market purchase | 12.5K | $2.00 | $25K |
Donald R. Chase is listed in SEC filings as a director of Bluejay Diagnostics, Inc. as of May 18, 2026. Public sources referenced in the SEC context do not provide extensive biographical detail beyond his board role, indicating that his prominence in public datasets is primarily due to board membership at Bluejay Diagnostics rather than broader public notoriety.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 1 open-market purchases ($25K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live CHASE DONALD R profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.